Clinical Report: Consensus from Indian Experts on Reducing Cardiovascular Risks in the Management of Prostate Cancer
Background
Prostate cancer is increasingly prevalent in India, particularly among older men, with many presenting at advanced stages. Concurrently, cardiovascular disease is a leading cause of non-cancer mortality in this population.
Data Highlights
No numerical data provided in the source material.
Key Findings
The PCCV Risk Expert Panel recommends comprehensive baseline lifestyle and cardiometabolic assessments for prostate cancer patients.
Patients should be stratified into low, intermediate, or high cardiovascular risk categories.
GnRH antagonists are preferred for high-risk patients, with referrals to cardiologists for those at intermediate or high risk.
Ongoing cardiometabolic monitoring and lifestyle interventions are essential components of care.
The ABCDE framework (Awareness, Blood Pressure, Cholesterol/Cigarettes, Diet/Diabetes, Exercise) should be integrated into patient management.
A multidisciplinary care model involving oncologists, urologists, cardiologists, and primary care providers is recommended.
Clinical Implications
Coordination among specialists is crucial to manage the risks associated with treatment.
Conclusion
The expert consensus emphasizes proactive cardiovascular risk management in prostate cancer care.
